Glycemic Effects of Postmenopausal Hormone Therapy: The Heart and Estrogen/progestin Replacement Study: A Randomized, Double-Blind, Placebo-Controlled Trial

Figure. Impaired fasting glucose was indicated by a serum glucose level of 6.0 to 6.9 µmol/L (110 to 125 mg/dL).
Figure. Impaired fasting glucose was indicated by a serum glucose level of 6.0 to 6.9 µmol/L (110 to 125 mg/dL). The flow diagram of the Heart and Estrogen/progestin Replacement Study.

This Article

  1. Ann Intern Med January 7, 2003 vol. 138 no. 1 1-9
  1. AbstractFREE
  2. Figures
  3. Full Text
  4. Full Text (PDF)

Current Issue

  1. December 15, 2009, 151 (12)
  1. Alert me to current issues